Abstract Details
|
PRESENTER |
No disclosure on file |
| Lecio Figueira Pinto, MD (Hospital Das Clinicas Sao Paulo) | No disclosure on file |
| Douglas M. Wallace, MD (Miami VA HealthCare System) | No disclosure on file |
| No disclosure on file | |
| Henry P. Moore, MD (University of Miami - Miller School of Medicine) | Dr. Moore has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Moore has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen Pharma. The institution of Dr. Moore has received research support from Sage Therapeutics. The institution of Dr. Moore has received research support from Bukwang Pharmaceutical. The institution of Dr. Moore has received research support from Neurocrine. The institution of Dr. Moore has received research support from CDHI Foundation. The institution of Dr. Moore has received research support from MODUS Outcomes LLC. |
| Corneliu C. Luca, MD (University of Miami) | Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Luca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Signant Health. Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. |
| Heather Katzen, PhD | Dr. Katzen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Adult Hydrocephalus Clinical Research Network. Dr. Katzen has received publishing royalties from a publication relating to health care. |
| Bonnie E. Levin, PhD | No disclosure on file |
| Carlos Singer, MD (University of Miami) | Dr. Singer has nothing to disclose. |